0 antall prosjekter

H20-INNOSUPSME-Innovation in SMEs

SN: The first blood biomarker to accurately STratify mortality Risk In patients with Cardiac arrhyTmia

SN: The first blood biomarker to accurately STratify mortality Risk In patients with Cardiac arrhyTmia

Tildelt: kr 1,2 mill.

Prosjektperiode: 2019-2020

Sted: Oslo

H20-INNOSUPSME-Innovation in SMEs

Secretoneurin (SN): the first blood biomarker to accurately stratify mortality risk in patients with cardiac arrhythmia

Cardiovascular disease (CVD) is the no. 1 killer worldwide. At least half of CVD deaths is caused by ventricular arrhythmias that lead to sudden cardiac death (SCD). The diagnosis of arrhythmias is difficult but crucial for accurate decision-making and patient survival, being more frequent and ca...

Tildelt: kr 0,48 mill.

Prosjektperiode: 2019-2020

Sted: Oslo